When cultured human keratinocytes reach confluence, they undergo a program of changes replicating features of differentiation in vivo, including exit from the proliferative pool, increased cell size, and expression of specialized differentiation marker proteins. Previously, we showed that insulin is required for some of these steps and that arsenite, a human carcinogen in skin and other epithelia, opposes the differentiation process. In present work, we show that insulin signaling, probably through the IGF-I receptor, is required for the increase in cell size accompanying differentiation and that this is opposed by arsenite. We further examine the impact of insulin and arsenite on PKCd, a known key regulator of keratinocyte differentiation, and show that insulin increases the amount, tyrosine phosphorylation, and membrane localization of PKCd. All these effects are prevented by exposure of cells to arsenite or to inhibitors of downstream effectors of insulin (phosphotidylinositol 3-kinase and mammalian target of rapamycin). Retrovirally mediated expression of activated PKCd resulted in increased loss of proliferative potential after confluence and greatly increased formation of cross-linked envelopes, a marker of keratinocyte terminal differentiation. These effects were prevented by removal of insulin, but not by arsenite addition. We further demonstrate a role for src family kinases in regulation of PKCd. Finally, inhibiting epidermal growth factor receptor kinase activity diminished the ability of arsenite to prevent cell enlargement and to suppress insulin-dependent PKCd amount and tyrosine 311 phosphorylation. Thus suppression of PKCd signaling is a critical feature of arsenite action in preventing keratinocyte differentiation and maintaining proliferative capability. ß
INTRODUCTION
Understanding the molecular effects of carcinogens can help elucidate normal cell function as well as pathological effects on target tissues. The salient molecular effects of inorganic arsenic remain enigmatic despite the variety of mechanisms that have been proposed by which it and its methylated metabolites act [1] . Arsenic targets a variety of tissues, eliciting adverse effects including carcinogenesis in skin, bladder, lung and possibly liver [2] , developmental defects in the lung [3] , atherosclerosis [4] and type 2 diabetes [5] . Arsenic and its methylated metabolites have been proposed to act by a variety of mechanisms [1] that may differ among tissue targets. A promising mouse model in which to examine such mechanisms displays carcinogenic effects in bladder, lung, and liver but not epidermis as a result of exposure in utero [6] . However, models have been developed with arsenite acting in the skin as a copromoter with phorbol ester in Tg.AC mice [7] or as a co-carcinogen with UV light [8] .
To complement mouse models, investigation in cultured human keratinocytes has proceeded as an imperfect but close approximation to arsenic action in the epidermis. With 3T3 feeder layer support, cultured keratinocytes proliferate rapidly until confluence, when they stratify, enlarge, accumulate proteins characteristic of the superficial layers of living epidermis and can develop cross-linked envelopes, a specific feature of the terminal stage of keratinocyte differentiation [9] . The differentiation process is accompanied by a gradual loss of proliferative potential, measured as a decrease in colony forming efficiency (CFE) after trypsinization and replating. In such cultures and in epidermis, cell size correlates positively with expression of the differentiation marker involucrin [10] and negatively with proliferative potential [11] .
Little additional information about signaling pathways regulating keratinocyte differentiationdependent increase in size has accumulated in the intervening decades, other than a requirement for oxygen near ambient atmospheric levels [12] , but recent observations in other systems suggest involvement of insulin and/or insulin-like growth factor-I (IGF-I). The insulin and IGF-I receptors are both strong activators of phosphatidylinositol 3-kinase (PI3-kinase) and its downstream effector, mammalian target of rapamycin (mTOR). In a complex with raptor, mTOR is a major regulator of protein synthesis through its effectors, S6 kinase and the initiation factor binding protein 4EBP, and thus has been demonstrated to play an important role in the general control of cell size [13] . Genetic disruption of components of this pathway leads to alterations in cell and organism size. The role of this signaling pathway in keratinocyte cell enlargement during differentiation is unknown.
Following initial observations that inorganic arsenic suppresses expression of keratinocyte differentiation markers in culture [14] , treated cells also were found to retain their proliferative potential after confluence [15] . Judging by the higher levels of b1-integrin and b-catenin and the higher fraction of cells that adhered rapidly to collagen-coated substrate, features demonstrated to be markers of keratinocyte stems cells [16] , arsenite exposure enhanced maintenance of stem cell properties. Subsequent work has shown these effects to require active epidermal growth factor (EGF) receptor. Added to the culture medium to stimulate growth to confluence, insulin induces EGF receptor loss after confluence, an effect antagonized by arsenite, which thereby suppresses differentiation and preserves proliferative potential [17] . Paralleling observations on the ability of arsenite to preserve stem cell character in cultured keratinocytes, the enhanced tumorigenicity due to arsenic exposure of Tg.AC mice was attributed in part to increased stem cell number as a target for carcinogenesis [18] .
Our observation that arsenic preserves keratinocyte stem cell character helps rationalize skin cancer as a consequence of exposure, but key signaling events underlying these phenomena remain to be elucidated. Previous results indicated that phorbol ester treatment could overcome certain effects of arsenite in keratinocytes, suggesting a role for protein kinase C (PKC) [19] . Findings that constitutive expression of the delta isoform (PKCd) can prevent skin tumor promotion in mice [20] , that PKCd is consistently lost in human skin carcinomas [21] and that PKCd is downstream of insulin signaling [22] raised the possibility this kinase is a target of arsenic action. Present experiments further characterize arsenite interference with insulin signaling and demonstrate a role for modulating PKCd, also a component of apoptotic response in keratinocytes [23, 24] .
MATERIALS AND METHODS

Cell Culture
Spontaneously immortalized keratinocytes (SIK) [25] or normal human epidermal cells derived from foreskin (passages 20-24 and 3-6, respectively) were propagated in DMEM/F12 (2:1) medium supplemented with fetal bovine serum (5%), hydrocortisone (0.4 mg/mL), adenine (0.18 mM), insulin (5 mg/mL, except where noted), transferrin (5 mg/mL) and triiodothyronine (20 pM) using a feeder layer of lethally irradiated 3T3 cells [26] . Medium was further supplemented with cholera toxin (10 ng/mL) at inoculation, which was replaced with EGF (10 ng/mL) starting at the first medium change. Cells were grown until just before confluence with medium changes at 3-to 4-d intervals, at which time they were treated with 2 mM sodium arsenite, 5 mM potassium antimony tartrate, 10 mM LY29003, 5 nM rapamycin (LC Laboratories, Waltham, MA), 5 nM wortmannin (Calbiochem/ EMD Chemicals, La Jolla, CA) or switched to medium without insulin. In certain instances, cells were first pretreated for 1 h with 1 mM AG1478 (LC Laboratories) or with 3 mM PP2 (Enzo Life Sciences, Plymouth Meeting, PA).
Retroviral and Lentiviral Infection of SIK
The cDNA encoding PKCd A147D activated pseudosubstrate mutant was subcloned into the retroviral vector pBabe-puro. A pBabe-puro vector only, used as control, or a PKCd construct was transfected into the retroviral packaging cell line Phoenix Ampho (kindly provided by Dr. Garry Nolan), and the retrovirus-containing medium was then used to infect SIK cultures in the presence of 4 mg/mL polybrene at 328C overnight. Infected cells were selected using 1 mg/mL puromycin. Immunoblotting showed the cells had approximately twice the relative amount of membrane-bound PKCd immunoreactivity. Lentiviral constructs encoding PKCd shRNAs were purchased from Sigma Chemical Co. (St. Louis, MO) and packaged using the lentiviral packaging system from Invitrogen (Carlsbad, CA). Cells were infected and selected as above.
Colony Forming Efficiency (CFE)
CFE was determined by inoculating 10 3 or 10 4 trypsinized cells in 6 cm dishes. Grown with feeder layer support until most were 2-5 mm in diameter, typically 10-14 d, the colonies were fixed and visualized by staining with Rhodanile blue [27] . CFE values (%) are presented as the number of colonies times 100 divided by the number of cells inoculated.
Cell Size
The size distribution of trypsinized cultures was determined using a Beckman Coulter Multisizer3 which calculates approximate diameters from the measured cell volumes assuming spherical shapes. As previously observed [12] , the calculated size distribution obtained in this way with normal epidermal cells is similar to that derived microscopically.
Spontaneous Envelope Formation
In suspension experiments, cultures were pretreated for 24 h with 2 mM arsenite before suspension in medium containing 1.4% methylcellulose and arsenite. After 4 d cells were recovered by low speed centrifugation, rinsed three times with isotonic phosphate-buffered saline, counted and resuspended in buffer containing 2% sodium dodecyl sulfate (SDS) and 20 mM dithiothreitol. After >30 min at room temperature, envelopes were counted by phase contrast optics in a hemocytometer. Envelope formation (%) is presented as the number of envelopes divided by the number of cells and multiplied by 100. Envelope formation in retrovirally infected surface cultures was measured by rinsing the cells with phosphate-buffered isotonic saline and dissolving them in buffer with 2% SDS and 20 mM dithiothreitol. After 30 min at room temperature, the cells were passed through a 25 gauge needle. Envelopes were centrifuged, rinsed in 0.1% SDS, resuspended in 1 mL of 0.1% SDS, examined microscopically, and relative amounts measured spectrophotometrically (A 340 ) by light scattering [28] .
Immunoblotting
For most experiments, cells were scraped directly into buffer containing 2% SDS, 62.5 mM Tris (pH 6.8) and 10% glycerol. Protein was measured with bicinchoninic acid [29] from Pierce Chemical (Rockford, IL) before addition of dithiothreitol to 50 mM and boiling for 3 min. In a given experiment, equal amounts (20 mg) of protein were submitted to SDSpolyacrylamide gel electrophoresis, transferred to polyvinyldifluoride membranes, blocked with 5% dry milk in Tris-buffered saline, 0.05% Tween-20, incubated with the indicated antibodies and detected using ECL Plus chemiluminescence detection reagent (GE Healthcare, Piscataway, NJ). Antibodies were obtained from the following sources: PKCd (rabbit polyclonal), phosphotyrosine (mouse monoclonal), phosphotyrosine 311 PKCd (rabbit polyclonal) from Santa Cruz Biotechnology (Santa Cruz, CA), actin (mouse monoclonal) from Sigma Chemical Co. and involucrin (rabbit polyclonal) [28] .
Immunoprecipitation
Cells were scraped into ice-cold phosphatebuffered isotonic saline and lysed in buffer containing 50 mM Tris-HCl, 300 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 1 mM b-glycerophosphate, 0.2 mM sodium vanadate, and EDTA-free protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN). Samples were disrupted by brief sonication and clarified by microfuge centrifugation. Protein concentration was determined using Coomassie G-250 [30] from Biorad (Richmond, CA). Protein lysates were precleared by incubation of 500 mg of protein for 1 h with 20 mL of protein A/G PLUS-agarose beads (Santa Cruz Biotechnology) at 48C with rotation. The preparations were then centrifuged at 1000g for 1 min. Supernatants were incubated with 4 mg of PKCd rabbit polyclonal antibody overnight at 48C with rotation followed by incubation with 20 mL protein A/G PLUS-agarose beads for 1 h. The complexes were recovered by centrifugation at 1000g for 1 min followed by three washes with lysis buffer, diluted in 2% SDS, 62.5 mM Tris (pH 6.8), 50 mM dithiothreitol and 10% glycerol and subjected to immunoblot analysis.
Cell Fractionation
Cultures were rinsed with ice-cold phosphatebuffered isotonic saline and scraped into buffer containing 20 mM Tris-HCl (pH 7.4), 5 mM EDTA, 1 mM sodium vanadate, 1 mM phenylmethylsulfonyl fluoride, and EDTA-free protease inhibitor cocktail (Roche). Cells were disrupted by sonication, centrifuged at 100 000g for 1 h at 48C, and supernatants were saved as a soluble fraction. Pellets were dissolved in 2% SDS, 62.5 mM Tris (pH 6.8) and 10% glycerol buffer and used as particulate fraction. Protein content was determined with bicinchononic acid (Pierce Chemical) before addition of dithiothreitol, and samples were subjected to immunoblot analysis.
Real-Time Reverse Transcription PCR
Total RNA was isolated using TRIzol reagent (Invitrogen). Contaminating genomic DNA was removed by pretreatment with DNase (DNA-free kit, Ambion, Austin, TX). c-DNA synthesis was performed using a High Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA). The cDNA served as a template in quantitative real-time PCR utilizing TaqMan Fast Universal PCR Master Mix and TaqMan Gene Expression assay probes for involucrin, keratins 1 and 10, keratinocyte transglutaminase (TGM1) and housekeeping genes GusB or b-actin (Applied Biosystems). The assays were performed in an ABI 7500 Fast Sequence Detection System. mRNA expression normalized to endogenous 18S RNA is presented relative to untreated control cultures in the presence of insulin (set to 1.0). Normalization to a housekeeping gene, GusB or b-actin, gave equivalent results.
Statistical Analysis
Except as noted, one-way ANOVA statistical testing (with Bonferroni corrections) was performed using Stata/SE9.2 software for Windows and threeway ANOVA by SAS. In certain cases, as noted, values from independent experiments were subjected to 2-tailed Student's t-testing using Excel for calculation of P values.
RESULTS
Arsenite and Insulin Have Opposing Effects on Keratinocyte Differentiation and Size
Previous work demonstrated opposing effects of arsenite and insulin on proliferative potential in the SIK line of keratinocytes [17] and in normal human epidermal cells ( [15] and Supplemental Tables 1 and  2 ). Since arsenite also suppresses differentiation marker expression [14] , we examined the possibility that removal of insulin, ordinarily added to stimulate cell growth, would have a similar effect. Like cells treated with arsenite, those cultured after confluence in the absence of insulin exhibited reduced levels of mRNAs encoding the differentiation markers keratin 1, keratin 10, involucrin, and TGM1 ( Figure 1A ). Long known to suppress such markers alone [31, 32] , EGF resulted in further suppression when added to arsenite-treated cultures.
Similar to normal human epidermal cultures [16] , SIK cells can be fractionated based on their adhesive properties. The cells that adhere most quickly to collagen-coated dishes have the highest proliferative potential [15] and smallest size (Supplemental Figure 1) . Consistent with the higher proliferative potential of small cells, cell size was decreased by treatment with arsenite or culture after confluence in the absence of insulin ( Figure 1B ). Arsenite and EGF together were more effective in preserving smaller cells than either alone. Insulin likely increased cell size due to its interaction with the IGF-I receptor since IGF-I was an order of magnitude more potent than insulin (Supplemental Figure 2) . Although several other metals and metalloids suppress differentiation marker expression [33] , only the chemically similar compounds, arsenite and antimonite, preserved proliferative potential [15] and small cell size (Supplemental Figure 3A) .
Arsenite and Insulin Modulate PKCd Status
When the keratinocyte cultures were held at confluence, total and particulate PKCd increased (Figure 2A ). Addition of arsenite (left panel) or removal of insulin (right panel) attenuated such increases. PKCd tyrosine phosphorylation was examined by immunoprecipitation from culture extracts. In parallel, total protein samples were probed with an antibody that recognizes phosphorylation of tyrosine 311 (Tyr 311), a major src family kinase site associated with modification of PKCd activity, substrate specificity, and stability [34] [35] [36] . Total tyrosine phosphorylation of PKCd, as well as phosphorylation on Tyr 311, increased Figure 1 . Keratinocyte size and differentiation after treatment with arsenite and EGF. Starting at confluence, cultures were treated in medium supplemented with the indicated combinations of 2 mM arsenite and 10 ng/mL EGF. Unless otherwise indicated, the medium contained 5 mg/mL insulin. After 7 d of treatment, cells were trypsinized and mRNA levels of involucrin, keratin 1, keratin 10, and TGM1 (A) or cell sizes (B) were measured. In (A), values are given relative to untreated cultures in the presence of insulin, normalized to 1. Data were compiled from three independent experiments. Significant differences from untreated (P < 0.01) are indicated by an asterisk (P ¼ 0.01 for involucrin, P < 0.01 for TGM1, P < 0.001 for KRT1 and P ¼ 0.001 for KRT10). in differentiating keratinocytes after confluence in the presence of insulin, while removal of insulin or addition of arsenite prevented both of these effects ( Figure 2B ). By contrast, neither potassium chromate, sodium vanadate nor cadmium chloride, at concentrations that suppressed insulin-dependent differentiation marker expression, reduced PKCd amount or phosphorylation (Supplemental Figure 4) .
PKCd Overexpression Induces Premature Keratinocyte Differentiation and Augments Accompanying Loss of Proliferative Potential
To explore the role of PKCd in keratinocyte differentiation and on proliferative potential, a constitutively active pseudosubstrate domain mutant [37, 38] was overexpressed in keratinocytes using retroviral infection. As a control, keratinocytes were infected with the empty vector, pBabe-puro. Differentiation marker mRNAs were measured by real-time PCR of RNA harvested from preconfluent cultures, which normally express only low levels of these mRNAs. Overexpression of PKCd was confirmed by an increase in its mRNA of nearly twofold compared to the vector control. This was accompanied by a 4.5-fold increase in involucrin mRNA compared to the matched vector control (4.5 AE 1.1 in three independent experiments, P ¼ 0.03 by two-tailed, paired t-test). In two experiments, TGM1, keratin 10, and filaggrin mRNAs also increased from 2-fold to 15-fold (not shown).
Envelope formation is an important final step of differentiation that occurs in culture after confluence or when cells are held in suspension. Unlike normal epidermal cells [39] , SIK cultures form few envelopes spontaneously after confluence, but a substantial fraction (20-25%) do so in suspension culture. As shown in Figure 3A , arsenite treatment decreased spontaneous envelope formation in suspension nearly by half compared to untreated cultures. In surface culture, PKCd overexpression greatly elevated the fraction of cells that spontaneously formed envelopes, a phenomenon that was not prevented by arsenite. In contrast, little spontaneous envelope formation induced by PKCd occurred in the absence of insulin ( Figure 3B ). Spontaneous envelopes were reduced by an average of 14.8 AE 1.7-fold when cells were infected with a lentiviral vector expressing any of four different PKCd shRNAs (P < 0.01 by t-test).
As previously reported [17] , the proliferative potential, measured by CFE, of control postconfluent keratinocytes maintained in standard medium containing insulin progressively decreased with time after confluence. Exposure to arsenite or removal of insulin prevented much of the decrease in colony forming ability ( Figure 4A ). In contrast, overexpression of PKCd further decreased keratinocyte proliferative potential by a week after confluence compared to the vector control (from 1.4 þ 0.4% in control to 0 in PKCd overexpressing cells in four experiments, P < 0.01 by t-test). Arsenite addition did not prevent the additional loss of proliferative potential in cells overexpressing PKCd, and the combination was lethal within 4 d after confluence. In contrast, insulin removal after confluence protected keratinocytes from the additional decrease in CFE mediated by PKCd overexpression.
Src Family Kinase Activity Is Required for PKCd Effects
When cultures were treated in the presence of insulin with PP2, an inhibitor of Src family kinases, phosphorylation of PKCd on Tyr 311 was prevented ( Figure 5A ), although this had little effect on distribution between particulate and soluble fractions. In addition the low level of Tyr 311 phosphorylation in the presence of arsenite was further decreased by PP2. Like arsenite, PP2 reduced cell size. Cultures treated with arsenite, PP2 or arsenite and PP2 (modal diameters 16-18 mm) all were noticeably smaller than untreated cultures (21 mm) ( Figure 5B ). PP2 also suppressed differentiation marker mRNA expression, and co-treatment with arsenite was even more effective ( Figure 5C ). Finally, PP2 treatment dramatically reversed the loss of colony forming ability after confluence of cells that overexpressed active PKCd ( Figure 5D ). These results suggest that, in the presence of insulin, a Src family kinase activity leads to phosphorylation on Tyr 311 of PKCd and promotes exit from the germinative pool and differentiation marker expression.
Inhibitors of Phosphatidylinositol 3-Kinase (PI3-Kinase) and mTOR Suppress Insulin Effects on Proliferative Potential and Differentiation
Since the PI3-kinase signaling pathway is strongly activated by insulin and IGF-I, we asked whether PI3- kinase and the downstream effector mTOR are required for insulin effects in keratinocytes. Inhibition of PI3-kinase with LY294002 ( Figure 6A ) or wortmanin (not shown) approximately doubled the CFE in treated cultures, nearly to the same extent as arsenite treatment. The mTOR inhibitor, rapamycin, was similarly effective. Either inhibitor in concert with arsenite produced a fourfold increase in CFE. A similar cooperative effect was observed on cell size (Supplemental Figure 5 ). Cultures treated with LY294002 had a modal size of 18 mm, similar to those treated with arsenite and noticeably smaller than the untreated control (21 mm). Cultures treated with both arsenite and LY294002 had a modal cell size of 14 mm, paralleling the increased CFE of the combined treatment. Arsenite and rapamycin together also reduced cell size further than either agent alone.
LY294002 and rapamycin each produced a substantial reduction in differentiation marker expression, similar to that produced by arsenite, and each in combination with arsenite was more effective ( Figure  6B ). In addition, LY294002 and rapamycin each decreased membrane localization of PKCd as well as its Tyr 311 phosphorylation, and each was more effective in combination with arsenite ( Figure 6C ).
Inhibiting insulin-signaling pathways also was found to have profound effects in cells overexpress- ing PKCd. Inhibition of PI3-kinase or mTOR (but not arsenite treatment) reversed the loss of proliferative potential elicited by expression of activated PKCd ( Figure 7A ). This effect was tested as well in a human squamous cell carcinoma culture (SCC9) in which PKCd was overexpressed ( Figure 7B ). In both cases (but more dramatically in SIK cultures), overexpression of PKCd decreased CFE. Insulin removal or treatment with rapamycin, an inhibitor of the downstream effector, mTOR/raptor complex, largely prevented the observed decrease in CFE.
EGF Receptor Activity Is Required for Arsenite Regulation of Differentiation Marker Expression and Cell Size
Inhibition of EGF receptor kinase activity has been shown to block the ability of arsenite to preserve proliferative potential of keratinocytes after confluence [15] . To determine whether other effects of arsenite require EGF receptor kinase action, cells were treated with the inhibitor AG1478. As shown in Figure 8A , the inhibitor prevented arsenite and antimonite from suppressing differentiation markers in the presence of insulin, but had no effect on the reduced differentiation marker expression in cells grown without insulin. In parallel experiments, the inhibitor had a small effect on cell size and did not affect the dramatic increase in diameter induced by insulin ( Figure 8B ). However, it did prevent arsenite ( Figure 8C ) and antimonite (Supplemental Figure 6 ) from maintaining a smaller cell size in the presence of insulin. Cells treated with arsenite or antimonite exhibited a modal diameter of 18 mm, whereas cells in the untreated cultures were considerably larger (modal diameter 22 mm). Addition of AG1478 to cultures treated with arsenite or antimonite resulted in a cell size distribution indistinguishable from the untreated control culture.
Finally, pretreatment of cultures with AG1478 reversed the suppressive effect of arsenite on total and membrane-localized PKCd levels as well as on Tyr 311 phosphorylation ( Figure 9A ). In contrast, AG1478 had little effect on the lack of the membrane-localized PKCd seen in cells cultivated without insulin ( Figure 9B ). In addition, even though AG1478 alone slightly increased pTyr 311 levels of PKCd in the presence of insulin, it did not lead to an increase in Tyr 311 phosphorylation in cultures without insulin. Effective only in the presence of insulin, EGF receptor activity appears targeted to preventing the insulin/IGF-I signaling required for differentiation.
DISCUSSION
Perturbation of cell behavior often facilitates deeper understanding of normal function. Thus, perturbation by arsenic has revealed the importance in keratinocytes of signaling through insulin or IGF-1 receptors. These receptors share elements of their signaling pathways but display differences in some downstream effects [40] . As shown by gene ablation studies in mice, signaling through the insulin receptor and, more profoundly, IGF-1R are important for the proper development and function of epidermis [41, 42] . In postconfluent human keratinocyte cultures, high concentrations of insulin permit normal differentiation, resulting in loss of germinative cells and decreased EGF receptor levels [17] , as well as the increased cell size and expression of differentiation markers shown here ( Figure 10 ). That all these features were prevented by removal of insulin after confluence or addition of arsenite to medium containing insulin indicates arsenite interferes with insulin/IGF-I signaling. Cell enlargement during differentiation evidently requires mTOR, since cell size is greatly diminished by rapamycin, a highly specific mTOR inhibitor.
The total amount of PKCd and its membrane translocation, as well as levels of tyrosine phosphorylation, increase during keratinocyte differentiation, effects now demonstrated to require insulin and to be prevented by arsenite. Decreased PKCd activity is associated with suppression of differentiation [43, 44] . On the other hand, overexpression of PKCd or h is sufficient to induce normal keratinocyte differentiation [45, 46] . Building on these findings, present results show that increased membrane localized PKCd parallels increased cell size and differentiation marker expression and decreased proliferative potential. More directly demonstrating the important role of PKCd in differentiation, overexpression of an activated pseudosubstrate domain PKCd mutant increased involucrin mRNA and crosslinked envelopes. The latter is a marker of the final state of terminal differentiation, a process that exhibits features in common with apoptosis [47] . In two experiments, PKCd overexpression in preconfluent keratinocytes also resulted in the appearance of a population of very large cells (>30 mm diameter) which were not present in preconfluent uninfected cells or in the vector control (unpublished data).
PKCd overexpression also accelerated the loss of proliferative potential that occurs after confluence in cultured keratinocytes. Proliferative potential declined in the keratinocytes infected with vector alone and in uninfected keratinocytes, perhaps because they also express substantial levels of PKCd. PKCd likely is not the sole factor resulting in loss of CFE, but it certainly contributes as evident by the augmentation induced by overexpression.
Overexpression of PKCd has been associated with induction of apoptosis in keratinocytes [23, 48] . In experiments reported here, Western blotting of SIK cultures after retroviral infection with a virus encoding activated PKCd showed increased differentiation marker expression, but no activated caspases, using antibodies to cleaved caspases 3, 7, 8, or 9 (unpublished). As a control for antibody reactivity, SIK cultures treated with staurosporine to induce apoptosis showed clear bands for cleaved caspases 3, 7, and 8. It is possible that transient caspase activation and subsequent apoptosis did occur in PKCd-expressing cells during puromycin selection, but was undetected later in the selected cells that were replated for analysis. Nevertheless, PKCd was increased in the selected cells, accompanied by increased differentiation marker expression. The outcome of PKCd overexpression, either differentiation or apoptosis, could depend on the amount of overexpression. Those cells expressing amounts that trigger apoptosis may have been lost during the drug selection, while cells induced to differentiate may be retained long enough to be replated and assayed.
Insulin signaling is known to activate PKC in several cell types [49] . An increase in PKCd activity after insulin stimulation is associated with altered tyrosine phosphorylation, mediated through src family kinases (SFK), and is PI3-kinase independent [50] . Direct interaction of PKCd with the insulin receptor results in activation of PKCd as well as an increase in insulin receptor tyrosine phosphorylation, internalization and signaling [51] . In addition, insulin can increase PKCd mRNA and protein levels in skeletal muscle [52] . Recent studies in murine keratinocytes indicate that PKCd is activated by insulin [22, 40] . Present results, showing increased membrane localization in the presence of insulin, emphasize the importance of this interaction for differentiation marker expression. The insulin requirement for overexpressed PKCd to accelerate loss of proliferative potential and envelope formation supports the proposition that PKCd is a key mediator of insulin-facilitated differentiation and/or apoptosis.
Human PKCd contains 20 tyrosine residues, several of which have been shown to be phosphorylated, leading either to increased or decreased activity [34] . Of these, Tyr 311, is in the hinge region and conforms to an SFK phosphorylation site. While the cell type and conditions can be critical, it is noteworthy that of several SFK members, Fyn, but not Syk, Src or Btk, associates with PKCd in activated platelets [53] . Furthermore, activation of platelets results in increased Tyr 311 phosphorylation, likely by Fyn itself since SFK can directly phosphorylate PKCd in vitro [35] . In platelets, membrane recruitment was required for Tyr 311 phosphorylation and was separately controlled by phospholipase C [54] .
In human keratinocytes, Tyr 311 phosphorylation was shown to be critical for PKCd-dependent activation of involucrin transcription [55] . Although the Tyr 311 kinase was not identified in that report, Fyn is plausibly responsible, since it has been identified as the kinase responsible for the phosphorylation that occurs after calcium stimulation of murine keratinocyte differentiation [48] . Fyn activity is increased in differentiating keratinocytes, leading to growth suppression, reduced EGF receptor signaling and increased differentiation marker expression [56, 57] . Furthermore, Fyn is required for proper epidermal function as knockout mice display abnormal differentiation [56] . In the presence of insulin, the general SFK inhibitor PP2 blocked the differentiation-dependent increase in cell size and differentiation marker expression. Clearly, it blocks a critical step in regulation, since it also prevented the effects of overexpressed PKCd. Although arsenite suppressed Tyr 311 phosphorylation, it did not prevent loss of proliferative potential or envelope formation as a result of PKCd overexpression. This finding could reflect the elevated level of the PKCd construct which, unlike the endogenous enzyme, was not suppressed by arsenite.
Present findings suggest the following model of cell signaling during keratinocyte growth and differentiation ( Figure 10 ). At low cell density, EGF receptor signaling is dominant and combines with insulin/IGF-I signaling to stimulate cell proliferation and prevent differentiation. When the cells reach confluence, insulin/IGF-I signaling acts as a pro-differentiation signal, perhaps the result of additional, as yet unknown, signaling generated at confluence. A critical consequence is loss of EGF receptor, removing a block to differentiation, a step prevented by arsenite exposure. Insulin/IGF-I signaling leads to activation of PI3-kinase and one of its downstream effectors, mTOR. Both kinases increase PKCd activity by increasing phosphorylation of priming sites in the activation loop (Thr505) and hydrophobic domain (Ser662). PDK1, which is activated by binding to phosphotidylinositol-3,4,5-triphosphate, the product of PI3-K, has been identified as the kinase responsible for Thr505 phosphorylation [58, 59] and mTOR as the hydrophobic domain kinase [60] . Insulin also induces the membrane translocation of PKCd, perhaps the result of phospholipase C activation. Membrane targeting brings PKCd into proximity with SFK which phosphorylate PKCd at Tyr 311, likely further increasing its activity [55] . This phosphorylation, abolished by the SFK inhibitor PP2, may be attributable to Fyn, which has been tied to keratinocyte differentiation [56] and is itself activated by another PKC family member, PKCh. The latter is not known to be regulated by insulin/ IGF-I signaling, but rather is dependent upon cholesterol sulfate, enriched in differentiating, suprabasal cells [61, 62] . Increased Tyr 311 phosphorylation of PKCd mediated by insulin is likely due to increased membrane translocation where it co-localizes with activated SFK. Since envelope formation depends upon elevated intracellular calcium, how PKCd activation impacts the function of the various calcium channels that have been identified in keratinocytes [63, 64] merits exploration. In addition, the potential impact of PKCd on activation of the skin tumor suppressor Notch1, also reduced by arsenic [65] , will be of interest.
